Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021

Descripción del Articulo

Introduction: The COVID-19 pandemic collapsed the health system, considered pregnant women as a vulnerable group and had a negative impact on access to health services, specifically prenatal care.Objective: To determine the clinical-epidemiological profile of pregnant women with COVID-19 infection t...

Descripción completa

Detalles Bibliográficos
Autores: León-Jacobo, Ruth, Sánchez-Vidal, Karina
Formato: artículo
Fecha de Publicación:2023
Institución:Sociedad Materno Fetal
Repositorio:Revista Internacional de Salud Materno Fetal
Lenguaje:español
OAI Identifier:oai:ojs2.ojs.revistamaternofetal.com:article/299
Enlace del recurso:http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299
Nivel de acceso:acceso abierto
Materia:Infección por coronavirus
Embarazo
Signos y síntomas
id REVSMF_c804a5de9ea4f53a866b0da2eb12a2fa
oai_identifier_str oai:ojs2.ojs.revistamaternofetal.com:article/299
network_acronym_str REVSMF
network_name_str Revista Internacional de Salud Materno Fetal
repository_id_str .
dc.title.none.fl_str_mv Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
Características clínicas y epidemiológicas de gestantes COVID positivo - Hospital Marino Molina Scippa 2020-2021
title Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
spellingShingle Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
León-Jacobo, Ruth
Infección por coronavirus
Embarazo
Signos y síntomas
title_short Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
title_full Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
title_fullStr Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
title_full_unstemmed Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
title_sort Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021
dc.creator.none.fl_str_mv León-Jacobo, Ruth
Sánchez-Vidal, Karina
author León-Jacobo, Ruth
author_facet León-Jacobo, Ruth
Sánchez-Vidal, Karina
author_role author
author2 Sánchez-Vidal, Karina
author2_role author
dc.subject.none.fl_str_mv Infección por coronavirus
Embarazo
Signos y síntomas
topic Infección por coronavirus
Embarazo
Signos y síntomas
description Introduction: The COVID-19 pandemic collapsed the health system, considered pregnant women as a vulnerable group and had a negative impact on access to health services, specifically prenatal care.Objective: To determine the clinical-epidemiological profile of pregnant women with COVID-19 infection treated at the Hospital Marino Molina Scippa between 2020 and 2021.Materials and Methods: Descriptive, retrospective and cross-sectional study in 298 pregnant women with a positive serological, antigen or PCR test, treated at the Gynecology and Obstetrics Service between 2020 and 2021. Medical records, birth book and epidemiological records were reviewed to collect sociodemographic variables, obstetric, epidemiological, clinical and newborn. The descriptive analysis was performed in SPSS v. 25.Results: The profile of the pregnant woman was an adult woman (64.8%), with a mean age of 31, secondary school (51.3%), cohabiting (72.8%), housewife (52.3%). , multigestation (35.9%) with 2.3 ± 1.3 pregnancies, uncontrolled (55.4%), without comorbidity (68.5%), 51.5% had normal delivery and newborn (NB) with normal Apgar (91.4%). The most frequent symptoms and signs were cough (11.9%), sore throat (9.8%), fever (7.4%), pharyngeal discharge (5.1%), and dyspnea (2.2%); 97.3% had the disease without complications. 47.3% were IgG reactive and 30.2% IgM IgG reactive, 78.2% did not know the contact person, of those who did, 32.3% indicated their husband and their home as the place of transmission (81.4%) or work (13.6%). Most of the NBs had no results, of those that did, 75.6% were IgG reactive and 13.5% IgG IgM reactive.Conclusions: The profile of the pregnant woman was adult, multigestational, uncontrolled, without comorbidity and the disease progressed without complications, 47.3% were diagnosed at a late stage (reactive IgG), the contact person was the husband and the place of transmission was his home. .
publishDate 2023
dc.date.none.fl_str_mv 2023-03-31
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299
url http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299/303
dc.rights.none.fl_str_mv Derechos de autor 2023 Revista Internacional de Salud Materno Fetal
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2023 Revista Internacional de Salud Materno Fetal
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Materno Fetal
publisher.none.fl_str_mv Sociedad Materno Fetal
dc.source.none.fl_str_mv Revista Internacional de Salud Materno Fetal; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14
International Journal of Mütterliche und fetale Gesundheit; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14
International Journal of Maternal and Fetal Health; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14
Revista Internacional de Saúde Materna e Fetal; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14
2519-9994
reponame:Revista Internacional de Salud Materno Fetal
instname:Sociedad Materno Fetal
instacron:RISMF
instname_str Sociedad Materno Fetal
instacron_str RISMF
institution RISMF
reponame_str Revista Internacional de Salud Materno Fetal
collection Revista Internacional de Salud Materno Fetal
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846336008653635584
spelling Clinical and epidemiological characteristics of COVID positive pregnant women - Hospital Marino Molina Scippa 2020-2021Características clínicas y epidemiológicas de gestantes COVID positivo - Hospital Marino Molina Scippa 2020-2021León-Jacobo, RuthSánchez-Vidal, KarinaInfección por coronavirusEmbarazoSignos y síntomasIntroduction: The COVID-19 pandemic collapsed the health system, considered pregnant women as a vulnerable group and had a negative impact on access to health services, specifically prenatal care.Objective: To determine the clinical-epidemiological profile of pregnant women with COVID-19 infection treated at the Hospital Marino Molina Scippa between 2020 and 2021.Materials and Methods: Descriptive, retrospective and cross-sectional study in 298 pregnant women with a positive serological, antigen or PCR test, treated at the Gynecology and Obstetrics Service between 2020 and 2021. Medical records, birth book and epidemiological records were reviewed to collect sociodemographic variables, obstetric, epidemiological, clinical and newborn. The descriptive analysis was performed in SPSS v. 25.Results: The profile of the pregnant woman was an adult woman (64.8%), with a mean age of 31, secondary school (51.3%), cohabiting (72.8%), housewife (52.3%). , multigestation (35.9%) with 2.3 ± 1.3 pregnancies, uncontrolled (55.4%), without comorbidity (68.5%), 51.5% had normal delivery and newborn (NB) with normal Apgar (91.4%). The most frequent symptoms and signs were cough (11.9%), sore throat (9.8%), fever (7.4%), pharyngeal discharge (5.1%), and dyspnea (2.2%); 97.3% had the disease without complications. 47.3% were IgG reactive and 30.2% IgM IgG reactive, 78.2% did not know the contact person, of those who did, 32.3% indicated their husband and their home as the place of transmission (81.4%) or work (13.6%). Most of the NBs had no results, of those that did, 75.6% were IgG reactive and 13.5% IgG IgM reactive.Conclusions: The profile of the pregnant woman was adult, multigestational, uncontrolled, without comorbidity and the disease progressed without complications, 47.3% were diagnosed at a late stage (reactive IgG), the contact person was the husband and the place of transmission was his home. .Introducción: La pandemia del COVID-19 colapsó el sistema de salud, consideró a las gestantes como grupo vulnerable e impacto negativamente en el acceso a los servicios de salud específicamente en la atención prenatal.Objetivo: Determinar el perfil clínico-epidemiológico de gestantes con infección por COVID-19 atendidas en el Hospital Marino Molina Scippa entre el 2020 y 2021.Materiales y Métodos: Estudio descriptivo, retrospectivo y transversal en 298 gestantes con prueba serológica, antígeno o PCR positiva, atendidas en el Servicio de Ginecoobstetricia entre el 2020 y 2021. Se revisaron historias clínicas, libro de nacimientos y fichas epidemiológicas para recolectar variables sociodemográficas, obstétricas, epidemiológicas, clínicas y del recién nacido. El análisis descriptivo se realizó en SPSS v. 25.Resultados: El perfil de gestante fue mujer adulta (64,8%), con una media de 31 años, de instrucción secundaria (51,3%), conviviente (72,8%), ama de casa (52,3%), multigesta (35,9%) con 2,3 ± 1,3 gestaciones, no controlada (55,4%), sin comorbilidad (68,5%), el 51,5% tuvo parto eutócico y recién nacido (RN) con Apgar normal (91,4%). Los síntomas y signos más frecuentes fueron tos (11,9%), dolor de garganta (9,8%), fiebre (7,4%) exudado faríngeo (5,1%) y disnea (2,2%); el 97,3% cursó la enfermedad sin complicaciones. El 47,3% fue IgG reactivo y el 30,2% IgM IgG reactivo, el 78,2% no sabía la persona de contacto, de las que sí, el 32,3% señaló al esposo y como lugar de transmisión su casa (81,4%) o trabajo (13,6%). En su mayoría, los RN no tuvieron resultado, de los que sí, el 75,6% fue IgG reactivo y 13,5% IgG IgM reactivo.Conclusiones: El perfil de gestante fue adulta, multigesta, no controlada, sin comorbilidad y cursó la enfermedad sin complicaciones, el 47.3% se diagnosticó en etapa tardía (IgG reactivo), la persona de contacto fue el esposo y el lugar de transmisión su casa.Sociedad Materno Fetal2023-03-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299Revista Internacional de Salud Materno Fetal; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14International Journal of Mütterliche und fetale Gesundheit; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14International Journal of Maternal and Fetal Health; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S14Revista Internacional de Saúde Materna e Fetal; Vol. 8 (2023): I Congreso Mundial de Obstetricia; S142519-9994reponame:Revista Internacional de Salud Materno Fetalinstname:Sociedad Materno Fetalinstacron:RISMFspahttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/299/303Derechos de autor 2023 Revista Internacional de Salud Materno Fetalhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:ojs2.ojs.revistamaternofetal.com:article/2992023-08-26T17:44:39Z
score 12.789266
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).